Loading…
Debio 025, a Cyclophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells When Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) Inhibitors
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...
Saved in:
| Published in: | Antimicrobial Agents and Chemotherapy 2009-03, Vol.53 (3), p.967-976 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-a472t-b25d2b939d94f50b4be136142896eb58f4143cdddf15b94d23d33b7f38bb64593 |
|---|---|
| cites | cdi_FETCH-LOGICAL-a472t-b25d2b939d94f50b4be136142896eb58f4143cdddf15b94d23d33b7f38bb64593 |
| container_end_page | 976 |
| container_issue | 3 |
| container_start_page | 967 |
| container_title | Antimicrobial Agents and Chemotherapy |
| container_volume | 53 |
| creator | Coelmont, Lotte Kaptein, Suzanne Paeshuyse, Jan Vliegen, Inge Dumont, Jean-Maurice Vuagniaux, Grégoire Neyts, Johan |
| description | Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
| doi_str_mv | 10.1128/AAC.00939-08 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_21340296</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>21340296</sourcerecordid><originalsourceid>FETCH-LOGICAL-a472t-b25d2b939d94f50b4be136142896eb58f4143cdddf15b94d23d33b7f38bb64593</originalsourceid><addsrcrecordid>eNp1kl9v0zAUxSMEYmPwxjO6T2iVmmHHTpq8IJUwaKUhJNaNR8tOnOZOrh3sdFM_MV8Dd63488CTZfl3z7k-OknympILSrPy3XxeXxBSsSol5ZPklJKqTIu8Kp4mp4QURcpLwk-SFyHckXjPK_I8OaEVJZxQdpr8_KgVOiBZPgUJ9a4xbujRoIUPaFu0a_jijG62Rk9hGWCB697s4LLrsEFtR4hgbbT0e3KhBzniiAFquEW_DXC-qG8n8E0PBhtn09rZUaLds7U2JsD3Xlu4CbqFuXFWg_OPgm6j0EYpZ-EBxx6uB91gdJQmeq-kX-txP2JHvEcvDax67eWwgy7OR0c4v17NV2k9gaXtUeHofHiZPOukCfrV8TxLbj5drupFevX187KeX6WSz7IxVVneZiqG2Va8y4niSlNWUJ6VVaFVXnaccta0bdvRXFW8zVjLmJp1rFSq4HnFzpL3B91hqza6bWJGcUMxeNxIvxNOovj3xWIv1u5eZEVOck6iwNujgHc_tjqMYoOhiWlJq902iIwyTrKqiOD0ADbeheB199uEErFvhojNEI_NEKSM-OSAy7DJxJ3behtz-B_75u9P_BE-1iYCcAD62IcH9FpEVSFlI3ImmKiKGfsFfRvM_Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21340296</pqid></control><display><type>article</type><title>Debio 025, a Cyclophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells When Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) Inhibitors</title><source>American Society for Microbiology Journals</source><source>PubMed Central</source><creator>Coelmont, Lotte ; Kaptein, Suzanne ; Paeshuyse, Jan ; Vliegen, Inge ; Dumont, Jean-Maurice ; Vuagniaux, Grégoire ; Neyts, Johan</creator><creatorcontrib>Coelmont, Lotte ; Kaptein, Suzanne ; Paeshuyse, Jan ; Vliegen, Inge ; Dumont, Jean-Maurice ; Vuagniaux, Grégoire ; Neyts, Johan</creatorcontrib><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.00939-08</identifier><identifier>PMID: 19104013</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Antiviral Agents ; Antiviral Agents - pharmacology ; Clinical Trials as Topic ; Cyclophilins - metabolism ; Cyclosporine ; Cyclosporine - pharmacology ; Dose-Response Relationship, Drug ; Drug Combinations ; Drug Synergism ; Hepacivirus ; Hepacivirus - drug effects ; Hepacivirus - genetics ; Hepacivirus - metabolism ; Hepatitis C ; Hepatitis C - drug therapy ; Hepatitis C - genetics ; Hepatitis C virus ; Humans ; Replicon - drug effects ; Ribavirin - pharmacology ; Viral Nonstructural Proteins ; Viral Nonstructural Proteins - antagonists & inhibitors ; Viral Nonstructural Proteins - genetics</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2009-03, Vol.53 (3), p.967-976</ispartof><rights>Copyright © 2009 American Society for Microbiology</rights><rights>Copyright © 2009, American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a472t-b25d2b939d94f50b4be136142896eb58f4143cdddf15b94d23d33b7f38bb64593</citedby><cites>FETCH-LOGICAL-a472t-b25d2b939d94f50b4be136142896eb58f4143cdddf15b94d23d33b7f38bb64593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.asm.org/doi/pdf/10.1128/AAC.00939-08$$EPDF$$P50$$Gasm2$$H</linktopdf><linktohtml>$$Uhttps://journals.asm.org/doi/full/10.1128/AAC.00939-08$$EHTML$$P50$$Gasm2$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,3188,3189,27924,27925,52751,52752,52753,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19104013$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Coelmont, Lotte</creatorcontrib><creatorcontrib>Kaptein, Suzanne</creatorcontrib><creatorcontrib>Paeshuyse, Jan</creatorcontrib><creatorcontrib>Vliegen, Inge</creatorcontrib><creatorcontrib>Dumont, Jean-Maurice</creatorcontrib><creatorcontrib>Vuagniaux, Grégoire</creatorcontrib><creatorcontrib>Neyts, Johan</creatorcontrib><title>Debio 025, a Cyclophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells When Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) Inhibitors</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>AAC</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><subject>Antiviral Agents</subject><subject>Antiviral Agents - pharmacology</subject><subject>Clinical Trials as Topic</subject><subject>Cyclophilins - metabolism</subject><subject>Cyclosporine</subject><subject>Cyclosporine - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Combinations</subject><subject>Drug Synergism</subject><subject>Hepacivirus</subject><subject>Hepacivirus - drug effects</subject><subject>Hepacivirus - genetics</subject><subject>Hepacivirus - metabolism</subject><subject>Hepatitis C</subject><subject>Hepatitis C - drug therapy</subject><subject>Hepatitis C - genetics</subject><subject>Hepatitis C virus</subject><subject>Humans</subject><subject>Replicon - drug effects</subject><subject>Ribavirin - pharmacology</subject><subject>Viral Nonstructural Proteins</subject><subject>Viral Nonstructural Proteins - antagonists & inhibitors</subject><subject>Viral Nonstructural Proteins - genetics</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp1kl9v0zAUxSMEYmPwxjO6T2iVmmHHTpq8IJUwaKUhJNaNR8tOnOZOrh3sdFM_MV8Dd63488CTZfl3z7k-OknympILSrPy3XxeXxBSsSol5ZPklJKqTIu8Kp4mp4QURcpLwk-SFyHckXjPK_I8OaEVJZxQdpr8_KgVOiBZPgUJ9a4xbujRoIUPaFu0a_jijG62Rk9hGWCB697s4LLrsEFtR4hgbbT0e3KhBzniiAFquEW_DXC-qG8n8E0PBhtn09rZUaLds7U2JsD3Xlu4CbqFuXFWg_OPgm6j0EYpZ-EBxx6uB91gdJQmeq-kX-txP2JHvEcvDax67eWwgy7OR0c4v17NV2k9gaXtUeHofHiZPOukCfrV8TxLbj5drupFevX187KeX6WSz7IxVVneZiqG2Va8y4niSlNWUJ6VVaFVXnaccta0bdvRXFW8zVjLmJp1rFSq4HnFzpL3B91hqza6bWJGcUMxeNxIvxNOovj3xWIv1u5eZEVOck6iwNujgHc_tjqMYoOhiWlJq902iIwyTrKqiOD0ADbeheB199uEErFvhojNEI_NEKSM-OSAy7DJxJ3behtz-B_75u9P_BE-1iYCcAD62IcH9FpEVSFlI3ImmKiKGfsFfRvM_Q</recordid><startdate>20090301</startdate><enddate>20090301</enddate><creator>Coelmont, Lotte</creator><creator>Kaptein, Suzanne</creator><creator>Paeshuyse, Jan</creator><creator>Vliegen, Inge</creator><creator>Dumont, Jean-Maurice</creator><creator>Vuagniaux, Grégoire</creator><creator>Neyts, Johan</creator><general>American Society for Microbiology</general><general>American Society for Microbiology (ASM)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>5PM</scope></search><sort><creationdate>20090301</creationdate><title>Debio 025, a Cyclophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells When Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) Inhibitors</title><author>Coelmont, Lotte ; Kaptein, Suzanne ; Paeshuyse, Jan ; Vliegen, Inge ; Dumont, Jean-Maurice ; Vuagniaux, Grégoire ; Neyts, Johan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a472t-b25d2b939d94f50b4be136142896eb58f4143cdddf15b94d23d33b7f38bb64593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Antiviral Agents</topic><topic>Antiviral Agents - pharmacology</topic><topic>Clinical Trials as Topic</topic><topic>Cyclophilins - metabolism</topic><topic>Cyclosporine</topic><topic>Cyclosporine - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Combinations</topic><topic>Drug Synergism</topic><topic>Hepacivirus</topic><topic>Hepacivirus - drug effects</topic><topic>Hepacivirus - genetics</topic><topic>Hepacivirus - metabolism</topic><topic>Hepatitis C</topic><topic>Hepatitis C - drug therapy</topic><topic>Hepatitis C - genetics</topic><topic>Hepatitis C virus</topic><topic>Humans</topic><topic>Replicon - drug effects</topic><topic>Ribavirin - pharmacology</topic><topic>Viral Nonstructural Proteins</topic><topic>Viral Nonstructural Proteins - antagonists & inhibitors</topic><topic>Viral Nonstructural Proteins - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Coelmont, Lotte</creatorcontrib><creatorcontrib>Kaptein, Suzanne</creatorcontrib><creatorcontrib>Paeshuyse, Jan</creatorcontrib><creatorcontrib>Vliegen, Inge</creatorcontrib><creatorcontrib>Dumont, Jean-Maurice</creatorcontrib><creatorcontrib>Vuagniaux, Grégoire</creatorcontrib><creatorcontrib>Neyts, Johan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Coelmont, Lotte</au><au>Kaptein, Suzanne</au><au>Paeshuyse, Jan</au><au>Vliegen, Inge</au><au>Dumont, Jean-Maurice</au><au>Vuagniaux, Grégoire</au><au>Neyts, Johan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Debio 025, a Cyclophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells When Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) Inhibitors</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>AAC</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2009-03-01</date><risdate>2009</risdate><volume>53</volume><issue>3</issue><spage>967</spage><epage>976</epage><pages>967-976</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><abstract>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>19104013</pmid><doi>10.1128/AAC.00939-08</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0066-4804 |
| ispartof | Antimicrobial Agents and Chemotherapy, 2009-03, Vol.53 (3), p.967-976 |
| issn | 0066-4804 1098-6596 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_21340296 |
| source | American Society for Microbiology Journals; PubMed Central |
| subjects | Antiviral Agents Antiviral Agents - pharmacology Clinical Trials as Topic Cyclophilins - metabolism Cyclosporine Cyclosporine - pharmacology Dose-Response Relationship, Drug Drug Combinations Drug Synergism Hepacivirus Hepacivirus - drug effects Hepacivirus - genetics Hepacivirus - metabolism Hepatitis C Hepatitis C - drug therapy Hepatitis C - genetics Hepatitis C virus Humans Replicon - drug effects Ribavirin - pharmacology Viral Nonstructural Proteins Viral Nonstructural Proteins - antagonists & inhibitors Viral Nonstructural Proteins - genetics |
| title | Debio 025, a Cyclophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells When Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) Inhibitors |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T14%3A51%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Debio%20025,%20a%20Cyclophilin%20Binding%20Molecule,%20Is%20Highly%20Efficient%20in%20Clearing%20Hepatitis%20C%20Virus%20(HCV)%20Replicon-Containing%20Cells%20When%20Used%20Alone%20or%20in%20Combination%20with%20Specifically%20Targeted%20Antiviral%20Therapy%20for%20HCV%20(STAT-C)%20Inhibitors&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=Coelmont,%20Lotte&rft.date=2009-03-01&rft.volume=53&rft.issue=3&rft.spage=967&rft.epage=976&rft.pages=967-976&rft.issn=0066-4804&rft.eissn=1098-6596&rft_id=info:doi/10.1128/AAC.00939-08&rft_dat=%3Cproquest_pubme%3E21340296%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a472t-b25d2b939d94f50b4be136142896eb58f4143cdddf15b94d23d33b7f38bb64593%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=21340296&rft_id=info:pmid/19104013&rfr_iscdi=true |